Letter: Upadacitinib in Perianal Crohn's Disease: Does Clinical Closure Reflect True Remission? Authors' Reply [0.03%]
乌帕替尼治疗肛周克罗恩病：临床愈合反映真正的缓解吗？作者答复
Nicolas Richard,Mathurin Fumery
Nicolas Richard
Impact of Inflammatory Activity on Anorectal Function in Patients With Ulcerative Colitis: A Prospective Study [0.03%]
炎症活动对溃疡性结肠炎患者肛直肠功能的影响：一项前瞻性研究
Ana Sanahuja Martínez,Pilar Mas Mercader,Joan Tosca Cuquerella et al.
Ana Sanahuja Martínez et al.
Objectives: Anorectal symptoms are common in ulcerative colitis (UC), yet the impact of inflammatory activity on anorectal function remains unclear. We evaluated the relationship between inflammatory activity and anorecta...
Editorial: MASLD In Primary Care-Risk-Stratification as the First Step to Treatment [0.03%]
论著：MASLD在初级保健中的风险分层是治疗的第一步
Niharika Samala
Niharika Samala
Long-Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long-Term Safety Extension [0.03%]
奥贝胆酸治疗原发性胆汁性胆管炎长期安全性和有效性的POISE研究最终结果
Christopher L Bowlus,Frederik Nevens,Kris V Kowdley et al.
Christopher L Bowlus et al.
Background: Obeticholic acid (OCA) has been evaluated in patients with primary biliary cholangitis (PBC) with inadequate response or intolerance to ursodeoxycholic acid (UDCA) in the 12-month, double-blind, phase 3 POISE ...
Editorial: Prediction of Survival in Hepatocellular Cancer-Rise and Fall of the Machines [0.03%]
述评： hepatocellular癌生存预测之机器崛起与衰落
Michael Pavlides
Michael Pavlides
Editorial: Sleeve Gastrectomy vs. Lifestyle Intervention-Redefining the Therapeutic Hierarchy for Adolescent MASLD? Authors' Reply [0.03%]
编辑来信：袖状胃切除术与生活方式干预——重新定义青少年MASLD治疗层次？作者回信
Toshifumi Yodoshi,Stavra A Xanthakos
Toshifumi Yodoshi
Inflammatory Bowel Disease Is Associated With an Increased Risk of End-Stage Renal Disease: A Population-Based Cohort Study [0.03%]
炎症性肠病与终末期肾病风险增加有关：基于人群的队列研究
Onuma Sattayalertyanyong,Zoann Nugent,Bryce Barr et al.
Onuma Sattayalertyanyong et al.
Background: Inflammatory bowel disease (IBD) is associated with renal complications, but population-based data on end-stage renal disease (ESRD) are limited. ...
Correction to 'Clinical Trial: Predicting Response to Iron Therapy in Patients With Active Inflammatory Bowel Disease Using Hepcidin and Functional Iron Indices: A Multicentre Randomised Trial' [0.03%]
关于“临床试验：使用铁调节素和功能性铁指标预测炎症性肠病患者对补铁治疗的反应的多中心随机试验”的更正
Published Erratum
Alimentary pharmacology & therapeutics. 2026 Jul 14. DOI:10.1111/apt.70861 2026